Primary chemotherapy versus primary surgery for ovarian cancer

Affiliations

¹ Department of Obstetrics and Gynaecology Campus Bio Medico University of Rome, 00128 Rome, Italy. Electronic address: g.scaletta@unicampus.it.
² Department of Obstetrics and Gynaecology Campus Bio Medico University of Rome, 00128 Rome, Italy.

Comment

Giuseppe Scaletta et al. Lancet. 2015.

. 2015 Nov 28;386(10009):2142.

doi: 10.1016/S0140-6736(15)01050-8.

¹ Department of Obstetrics and Gynaecology Campus Bio Medico University of Rome, 00128 Rome, Italy. Electronic address: g.scaletta@unicampus.it.
² Department of Obstetrics and Gynaecology Campus Bio Medico University of Rome, 00128 Rome, Italy.

No abstract available

Comment in

Primary chemotherapy versus primary surgery for ovarian cancer - Authors' reply.
Kehoe S, Nankivell M. Kehoe S, et al. Lancet. 2015 Nov 28;386(10009):2143. doi: 10.1016/S0140-6736(15)01052-1. Lancet. 2015. PMID: 26638963 No abstract available.

Primary chemotherapy versus primary surgery for newly diagnosed advanced ovarian cancer (CHORUS): an open-label, randomised, controlled, non-inferiority trial.
Kehoe S, Hook J, Nankivell M, Jayson GC, Kitchener H, Lopes T, Luesley D, Perren T, Bannoo S, Mascarenhas M, Dobbs S, Essapen S, Twigg J, Herod J, McCluggage G, Parmar M, Swart AM. Kehoe S, et al. Lancet. 2015 Jul 18;386(9990):249-57. doi: 10.1016/S0140-6736(14)62223-6. Epub 2015 May 19. Lancet. 2015. PMID: 26002111 Clinical Trial.